Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 286 Records) |
| Query Trace: Recurrence and EGFR[original query] |
|---|
| EGFR mutation prevalence, real-world treatment patterns, and outcomes among patients with resected, early-stage, non-small cell lung cancer in Canada. Lung cancer (Amsterdam, Netherlands) 2022 Sep 173 58-66. Sara Kuruvilla M, Liu Geoffrey, Syed Iqra, Gwadry-Sridhar Femida, Sheffield Brandon S, Sachdeva Robin, Pencz Alec, Zhan Luna, Hueniken Katrina, Patel Devalben, Balaratnam Karmugi, Khan Khaleeq, Grant Benjamin, Noy Shawna, Singh Karan, Liu Linda, Rakibuz-Zaman Muhammad, Moldaver Daniel, Kate Shanahan Mary, Cheema Parneet |
| Advances in the treatment of postoperative recurrence of non-small cell lung cancer and their impact on survival in Asian patients. The Journal of thoracic and cardiovascular surgery 2022 Aug . Hashimoto Kohei, Ariyasu Ryo, Ichinose Junji, Matsuura Yosuke, Nakao Masayuki, Amino Yoshiaki, Uchibori Ken, Kitazono Satoru, Yanagitani Noriko, Okumura Sakae, Nishio Makoto, Mun Mingy |
| Epithelial TGF? engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features. Nature communications 2022 12 13 (1): 7551. Flanagan Dustin J, Amirkhah Raheleh, Vincent David F, Gunduz Nuray, Gentaz Pauline, Cammareri Patrizia, McCooey Aoife J, McCorry Amy M B, Fisher Natalie C, Davis Hayley L, Ridgway Rachel A, Lohuis Jeroen, Leach Joshua D G, Jackstadt Rene, Gilroy Kathryn, Mariella Elisa, Nixon Colin, Clark William, Hedley Ann, Markert Elke K, Strathdee Douglas, Bartholin Laurent, Redmond Keara L, Kerr Emma M, Longley Daniel B, Ginty Fiona, Cho Sanghee, Coleman Helen G, Loughrey Maurice B, Bardelli Alberto, Maughan Timothy S, Campbell Andrew D, Lawler Mark, Leedham Simon J, Barry Simon T, Inman Gareth J, van Rheenen Jacco, Dunne Philip D, Sansom Owen |
| PD-L1 Expression is not a Predictive Factor for Recurrence in Resected Non-small Cell Lung Cancer. Lung 2022 12 201 (1): 95-101. Motono Nozomu, Mizoguchi Takaki, Ishikawa Masahito, Iwai Shun, Iijima Yoshihito, Uramoto Hideta |
| A prognostic risk model for glioma patients by systematic evaluation of genomic variations. iScience 2022 12 25 (12): 105681. Zhang Baifeng, Wan Weiqing, Li Zibo, Gao Zhixian, Ji Nan, Xie Jian, Wang Junmei, Wang Bin, Lai-Wan Kwong Dora, Guan Xinyuan, Gao Shengjie, Zhao Yuanli, Lu Youyong, Zhang Liwei, Rodland Karin D, Tsang Shirley |
| The Effect of Gefitinib on Treatment Necessity and Prognosis of NSCLC Patients with Early EGFR Mutations. Contrast media & molecular imaging 2022 10 2022 2228744. Song Ruiqiang, Cheng Yanbo, Zheng Tian |
| Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer. FEBS open bio 2022 Oct . Xu Fei, Cui Wen-Qiang, Liu Cun, Feng Fubin, Liu Ruijuan, Zhang Jingtao, Sun Chang-Ga |
| EGFR Mutation-Positive Unresectable Stage III Non-Squamous Lung Cancer is Associated with a High Incidence of Brain Metastasis. Cancer research and treatment 2022 Oct . Kim Hongsik, Park Sehhoon, Jung Hyun Ae, Sun Jong-Mu, Lee Se-Hoon, Ahn Jin Seok, Ahn Myung- |
| EGFR co-mutation is associated with the risk of recurrence in invasive lung adenocarcinoma with the micropapillary component. Asian journal of surgery 2023 8 . Haixin Kang, Haiyan Lv, Tao-Hsin Tung, Dehua Ma, Zheng Wang, Juping Du, Kai Zhou, Juan Pan, Yanjie Zhang, Shuotao Peng, Zhaonan Yu, Bo Shen, Minhua |
| Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer. Frontiers in oncology 2023 7 13 1116809. Qiyu Fang, Xiaoying Wan, Angelica D'Aiello, Hui Sun, Weiquing Gu, Yixue Li, Caicun Zhou, Boxiong Xie, Qinfang Deng, Haiying Cheng, Songwen Zh |
| Clinical Impact of Genomic and Pathway Alterations in Stage I EGFR-Mutant Lung Adenocarcinoma. Cancer research and treatment 2023 7 . Jae Seok Lee, Eun Kyung Kim, Kyung A Kim, Hyo Sup Sh |
| Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC. The New England journal of medicine 2023 6 . Masahiro Tsuboi, Roy S Herbst, Thomas John, Terufumi Kato, Margarita Majem, Christian Grohé, Jie Wang, Jonathan W Goldman, Shun Lu, Wu-Chou Su, Filippo de Marinis, Frances A Shepherd, Ki Hyeong Lee, Nhieu Thi Le, Arunee Dechaphunkul, Dariusz Kowalski, Lynne Poole, Ana Bolanos, Yuri Rukazenkov, Yi-Long Wu, |
| Evaluation of the Analytical Performance of Oncomine Lung cfDNA Assay for Detection of Plasma EGFR Mutations. Genes 2023 6 14 (6): . Yong Gon Cho, Joonhong Park, Ji Yoon Han, Tae Yun K |
| Association Between 18F-Fluorodeoxyglucose Uptake and Mutation Status of Epidermal Growth Factor Receptor in Sinonasal Tract Cancer. Anticancer research 2023 6 43 (7): 3247-3253. Hidenori Suzuki, Eiichi Sasaki, Tsuneo Tamaki, Takeshi Kodaira, Masami Nishio, Daisuke Nishikawa, Shintaro Beppu, Hoshino Terada, Michi Sawabe, Nobuhiro Han |
| The prognostic impact of epidermal growth factor receptor mutation in clinical stage I lung adenocarcinoma. The Annals of thoracic surgery 2023 6 . Fujun Yang, Ke Sun, Fei Li, Xiang Li, Jinghan Shi, Xiwen Sun, Yong Hong, Gening Jiang, Yuming Zhu, Xiao So |
| An oncogenic CTNNB1 mutation is predictive of post-operative recurrence-free survival in an EGFR-mutant lung adenocarcinoma. PloS one 2023 6 18 (6): e0287256. Yeseul Kim, Bokyung Ahn, Shinkyo Yoon, Goeun Lee, Deokhoon Kim, Sung-Min Chun, Hyeong-Ryul Kim, Se Jin Jang, Hee Sang Hwa |
| Significance of the FGFR3 mutation in Chinese patients with bladder cancer. Translational andrology and urology 2023 6 12 (5): 761-769. Lanxiang Hao, Jiang Fang, Ran Xu, Shuo Liu, Guangcheng Luo, Xinjun Wa |
| Longitudinal Monitoring of Circulating Tumor DNA From Plasma in Patients With Curative Resected Stage I-IIIA EGFR Mutant-Non-Small Cell Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 6 . Hyun-Ae Jung, Bo Mi Ku, Yeon Jeong Kim, Sehhoon Park, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Jong Ho Cho, Hong Kwan Kim, Yong Soo Choi, Yoon-La Choi, Sun Hye Shin, Byeong-Ho Jeong, Sang-Won Um, Hojoong Kim, Kyunga Kim, Myung-Ju Ahn, Jhingook K |
| Investigation of EGFR and ALK mutation frequency and treatment results in advanced non-small cell lung cancer. Journal of cancer research and therapeutics 2023 5 19 (Supplement): S183-S190. Berna Komurcuoglu, Gamze Karakurt, Ozge O Kaya, Gulden Diniz, Ozgür K?rb?y?k, Aysen Evkan, Enver Yaln |
| T790M and Acquired Resistance of Epidermal Growth Factor Receptor to Tyrosine Kinase Inhibitors in Patients with Lung Adenocarcinoma. Tanaffos 2023 4 21 (3): 376-383. Mirtavoos-Mahyari Hanifeh, Abbasi Dezfouli Azizollah, Esfahani-Monfared Zahra, Khosravi Adnan, Seifi Sharareh, Sheikhy Kamb |
| Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma. BMC cancer 2023 3 23 (1): 248. Ito Masaoki, Miyata Yoshihiro, Kushitani Kei, Ueda Daisuke, Takeshima Yukio, Okada Morihi |
| Almonertinib Combined with Anlotinib and Temozolomide in a Patient with Recurrent Glioblastoma with EGFR L858R Mutation. The oncologist 2023 3 . Hou Zhiwei, Wu Huaguo, Luo Ningning, Li Shuo, Zhang Xiang, Dong Shuai, Zhu Dongyuan, Zhang Hui, Tao Rongj |
| Risk Factors for Recurrence of Stage I Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma. The Annals of thoracic surgery 2023 2 . Kamigaichi Atsushi, Mimae Takahiro, Tsubokawa Norifumi, Miyata Yoshihiro, Adachi Hiroyuki, Shimada Yoshihisa, Ito Hiroyuki, Ikeda Norihiko, Okada Morihi |
| Different prognostic role of EGFR mutation according to the IASLC histologic grade in patients with resected early-stage lung adenocarcinoma. Histopathology 2023 2 . Hong Tae Hee, Hwang Soohyun, Choi Yoon-La, Lee Genehee, Park Sehhoon, Ahn Myung-Ju, Lee Yoonseo, Jeon Yeong Jeong, Lee Junghee, Shin Sumin, Park Seong Yong, Cho Jong Ho, Choi Yong Soo, Kim Jhingook, Shim Young Mog, Cho Juhee, Kim Hong Kw |
| Efficacy of adjuvant chemotherapy in stage II/III NSCLC with EGFR mutation. The Thoracic and cardiovascular surgeon 2023 2 . Matsunaga Takeshi, Takamochi Kazuya, Hattori Aritoshi, Fukui Mariko, Suzuki Ken |
| ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing. Gynecologic oncology 2023 2 171 59-66. Machida Hiroko, Matsuo Koji, Tanaka Masayuki, Kitatani Kanae, Takase Akinori, Yokoyama Keiko, Kajiwara Hiroshi, Yasaka Miwa, Ikeda Masae, Yoshida Hiroshi, Hirasawa Takeshi, Mikami Mik |
| Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors. JCO precision oncology 2023 2 7 e2200465. Ardeshir-Larijani Fatemeh, Schneider Bryan P, Althouse Sandra K, Radovich Milan, Masood Ashiq, Perna Fabiana, Salman Huda, Loehrer Patrick |
| [Correlation Analysis of Ki67 Expression and EGFR Mutation on the Risk of Recurrence and Metastasis in Postoperative Patients with Stage I Lung Adenocarcinoma]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2023 1 25 (12): 852-861. Xu Lili, Guo Renh |
| Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 1 JCO2202186. Herbst Roy S, Wu Yi-Long, John Thomas, Grohe Christian, Majem Margarita, Wang Jie, Kato Terufumi, Goldman Jonathan W, Laktionov Konstantin, Kim Sang-We, Yu Chong-Jen, Vu Huu Vinh, Lu Shun, Lee Kye Young, Mukhametshina Guzel, Akewanlop Charuwan, de Marinis Filippo, Bonanno Laura, Domine Manuel, Shepherd Frances A, Urban Damien, Huang Xiangning, Bolanos Ana, Stachowiak Marta, Tsuboi Masahi |
| Clinical characteristics and prognostic value of EGFR mutation in stage I lung adenocarcinoma with spread through air spaces after surgical resection. Neoplasma 2023 1 69 (6): 1480-1489. Gao Mao-Gang, Wang Shi-Ze, Han Kai-Hong, Xie Shao-Nan, Liu Qing- |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: